Immunome Inc (IMNM)

$14.80 0.08 (0.54%)

16:00 EDT IMNM Stock Quote Delayed 30 Minutes

IMNM Stock Earnings: Immunome Beats EPS, Misses Revenue for Q1 2024

By InvestorPlace Earnings May 14, 2024

IMNM stock results show that Immunome beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

IMNM Stock Earnings: Immunome Beats EPS, Beats Revenue for Q4 2023

7 Biotech Stocks to Get In Now Before Investors Catch On

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

More Articles

Volume:

Previous Close -

Market Cap 887.54M

PE Ratio -1.96

EPS -7.55

Volume (Avg. Vol.) 935,341

Day's Range $14.66 - $15.73

52-Week Range $4.50 - $30.96

Dividend & Yield N/A (N/A)

IMNM Stock Predictions, Articles, and Immunome Inc News

From InvestorPlace
From the Web

IMNM Stock: The Covid Treatment News That Has Immunome Soaring Today

By Brenden Rearick, InvestorPlace Financial News Writer Jul 20, 2021

IMNM stock is having a great day today. The company is preparing to move forward with expedited testing for its delta variant treatment.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday Morning

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Apr 26, 2021

Want to get ready for the trading week? These pre-market stock movers will help you prep with the latest news driving the stock market.

IMNM Stock: The Big News That Has Biotech Play Immunome Blasting Higher

By William White, InvestorPlace Writer Feb 18, 2021

Immunome (IMNM) stock is rocketing higher on Thursday after announcing an update concerning its vaccine research for the novel coronavirus.

Immunome down 1%, prices $200M equity (NASDAQ:IMNM)

From Seeking Alpha Feb 14, 2024

Biotechnology company Immunome prices underwritten public offering of 10M shares at $20.00 per share, expecting $200M gross proceeds.

Immunome files for automatic mixed securities shelf (NASDAQ:IMNM)

From Seeking Alpha Feb 13, 2024

Immunome (IMNM) has filed a prospectus for the offer and sale of automatic mixed securities shelf.

Immunome announces underwritten public offering of common stock (NASDAQ:IMNM)

From Seeking Alpha Feb 13, 2024

Immunome (IMNM) plans $200 million public offering of common stock with an option for underwriters to purchase additional shares.

Immunome appoints Phil Roberts as chief technical officer (NASDAQ:IMNM)

From Seeking Alpha Jan 4, 2024

Immunome announces the appointment of Phil Roberts as Chief Technical Officer.

Immunome a new outperform at Wedbush on cancer platforms

From Seeking Alpha Dec 19, 2023

Wedbush initiates Immunome at outperform, highlighting its potential to develop effective antibody therapies for cancer. Read more here.

Short Volatility Alert: Immunome, Inc.

From Benzinga May 24, 2022

On Modnay, shares of Immunome, Inc. (NASDAQ: IMNM) experienced volatile short activity. After the activity, the stock price went up +0.30% to $3.31. The overall sentiment for IMNM has been Bearish.

ADVERTISEMENT